Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy 2022-06-15 Health critical FDA
Health · FDA · Recall #FDA-D-1167-2022
Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication.,… Recall
Issued June 15, 2022 · Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy
In June 2022, Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy recalled the Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication.,…, a critical health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Subpotent drug
What you should do
- 1 Stop using Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication.,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy
- Category
- Health
- Recall date
- June 15, 2022
- Units affected
- Not reported
- Sold at
- CA
- Recall number
- FDA-D-1167-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy has 1 recall in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.